Cibinqo (abrocitinib) is a once-daily pill for eczema. It is indicated for the treatment of adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. Rapid Relief from Itch and… Read More
Opzelura – A JAK Inhibitor for use in Dermatology
Opzelura is a revolutionary prescription cream that offers a steroid-free approach to managing two common skin conditions: atopic dermatitis (eczema) and nonsegmental vitiligo. Opzelura for Eczema If you struggle with the itchy, red, and inflamed patches of eczema, you know how frustrating and debilitating it can be. Opzelura provides rapid relief from itching and inflammation,… Read More
Adbry for Atopic Dermatitis
Adbry is the brand name for tralokinumab-ldrm. It is approved for the treatment of atopic dermatitis, commonly referred to as eczema, a chronic skin condition characterized by itching, redness, and inflammation. Adbry is approved for those with moderate-to-severe atopic dermatitis who have not responded well to other treatments. Tralokinumab is a monoclonal antibody, a type… Read More
Peanut Allergy And Eczema
The prevalence of peanut allergy among children in the United States has risen dramatically in recent years. Recent studies have proposed a link between atopic dermatitis (often just called eczema by non-physicians) and peanut allergy. It is theorized that exposure to peanut allergens through skin increases the risk of developing peanut allergy, while eating peanuts… Read More
Dupilumab for Atopic Dermatitis
Dupilumab (brand name Dupixent) is shaping up to be a game-changer in the treatment of atopic dermatitis, often referred to informally as “eczema”. Dupixent addresses an underlying immune dysregulation that contributes to the development of atopic dermatitis. It blocks IL-4 and IL-13, two important cytokines in the TH2 pathway. In a clinical trial, after 12… Read More
Eczema Therapeutic Ladder
Call 973-763-7546 To Schedule Your Eczema Consultation Atopic dermatitis, usually called eczema, is one of the most common conditions encountered in dermatology, with itch typically the paramount symptom. Treating atopic dermatitis usually starts with a gradual escalation of treatments up the therapeutic ladder. Topical Therapies For Atopic Dermatitis Emollients and Skin Care. The use of… Read More
Eucrisa Approved for Eczema
The U.S. Food and Drug Administration recently approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older. This is the first major new treatment option in atopic dermatitis in quite some time, and will be a welcome addition to the typical steroid options. Eucrisa, applied… Read More
